ARCHIVES

“Harm-Reduction” Products No Proven, IOM Report Says.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Considering Master Agreements For Cancer Centers

August 2, 1991

Sledge Elected ASCO President

January 16, 2009

DCT Board Ok’s concept For In Vivo Combination Studies

November 23, 1990

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

Compendia Publishers Must Tell CMS How They Manage Conflicts Of Interest

November 13, 2009

Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines?

March 19, 2004